These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3274421)

  • 1. The effect of cyclosporine on long-term function in patients undergoing kidney transplant from living donors.
    Alfani D; Berloco P; Renna Molajoni E; Pretagostini R; Famulari A; Sallustio F; Caricato M; Rossi M; Pecorella I; Ciardi A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1759-60. PubMed ID: 3274421
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity.
    Post GR; Moyer TP; Anderson CF; Sterioff S
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1761-3. PubMed ID: 3079036
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
    Kupin W; Venkat KK; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
    [No Abstract]   [Full Text] [Related]  

  • 4. Early and late complications of cyclosporine treatment in a 5-year follow-up of 250 renal transplant recipients.
    Civati G; Busnach G; Perrino ML; Broggi ML; Brando B; Seveso M; Minetti L
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1571-2. PubMed ID: 2652510
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats.
    Yagisawa T; Takahashi K; Teraoka S; Toma H; Agishi T; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1801-3. PubMed ID: 3079039
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
    Hillebrand G; Castro LA; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2179-80. PubMed ID: 2856280
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with triple immunosuppressive therapy in living related donor kidney transplantation.
    Kostakis A; Homatas J; Kyriakidis S; Garbis S; Zavos G; Sotirchos G; Diles K; Bokos J; Stathakis C; Boletis J
    Transplant Proc; 1991 Aug; 23(4):2223. PubMed ID: 1871854
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple and quadruple therapy after renal transplantation in patients from developing countries.
    Slapak M; Shell T; Digard N; Gosling DC; Qerchi della Rovera G; Crockett RC; Ahmed K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1922-5. PubMed ID: 3547896
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
    De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of cyclosporine treatment in renal transplantation.
    Tilney NL; Milford EL; Carpenter CB; Lazarus JM; Strom TB; Kirkman RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):179-85. PubMed ID: 3083548
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-year follow-up of graft function and urinary protein excretion in kidney transplant patients immunosuppressed with cyclosporine or azathioprine.
    Widstam-Attorps U; Bergström J; Lefvert AK
    Transplant Proc; 1990 Feb; 22(1):216. PubMed ID: 2309319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclosporin versus azathioprine].
    Manganoni AM; Gavazzoni R; Calzavara Pinton PG; Graifemberghi S; Manganoni A; Scolari F; Sandrini S
    G Ital Dermatol Venereol; 1986; 121(6):453-5. PubMed ID: 2951323
    [No Abstract]   [Full Text] [Related]  

  • 15. An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients.
    Salomon DR
    Transplant Proc; 1991 Aug; 23(4):2115-8. PubMed ID: 1871827
    [No Abstract]   [Full Text] [Related]  

  • 16. Is cyclosporine administration in twice daily dose advantageous?
    Savoldi S; Sandrini S; Scolari F; Brunori G; Prati E; Camerini C; Scaini P; Cristinelli L; Maiorca R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1720-2. PubMed ID: 3274414
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of increased serum calcium fractions with the onset of cyclosporine-associated hypertension in renal transplant patients.
    Buscemi G; Giannetto V; Vaccaro F; Locascio G; Picone FP; Bellavia C; Romano M; Rapisarda LM
    Transplant Proc; 1987 Oct; 19(5):4003-4. PubMed ID: 3313984
    [No Abstract]   [Full Text] [Related]  

  • 19. Elective conversion from cyclosporine to azathioprine: long-term follow-up.
    Veitch PS; Taylor JD; Feehally J; Walls J; Bell PR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2017. PubMed ID: 3079067
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.